Seminars in Oncology
Volume 37, Issue 3 , Pages 243-257 , June 2010

Cellular Proliferation, Apoptosis and Angiogenesis: Molecular Targets for Nutritional Preemption of Cancer

  • Cindy D. Davis

      Affiliations

    • Corresponding Author InformationAddress correspondence to Cindy D. Davis, PhD, Nutritional Science Research Group, Division of Cancer Prevention, National Cancer Institute, 6130 Executive Blvd, Suite 3159, Rockville, MD 20892-7328
  • ,
  • Nancy J. Emenaker
  • ,
  • John A. Milner

References 

  1. World Cancer Research Fund/American Institute for Cancer Research. Food nutrition, physical activity and the prevention of cancer: a global perspective; Washington, DC.
  2. Milner JA. Molecular targets for bioactive food components. J Nutr. 2004;134:2492s–2498s
  3. Liu RH. Health benefits of fruit and vegetables are from additive and synergistic combinations of phytochemicals. Am J Clin Nutr. 2003;78:517S–520S
  4. Davis CD. Nutritional interactions: credentialing of molecular targets for cancer prevention. Exp Biol Med. 2007;232:176–183
  5. Liu RH. Health benefits of fruit and vegetables are from additive and synergistic combinations of phytochemicals. Am J Clin Nutr. 2003;78:517s–520s
  6. Yu S, Kong A-N. Targeting carcinogen metabolism by dietary cancer preventive compounds. Current Cancer Drug Targets. 2007;5:416–424
  7. Mathers JC, Coxhead JM, Tyson J. Nutrition and DNA repair-potential molecular mechanisms of action. Current Cancer Drug Targets. 2007;5:425–431
  8. Encisco JM, Hirschi KK. Nutrient regulation of tumor and vascular endothelial cell proliferation. Current Cancer Drug Targets. 2007;5:432–437
  9. Martin KR. Using nutrigenomics to evaluate apoptosis as a preemptive target in cancer prevention. Current Cancer Drug Targets. 2007;5:438–446
  10. Surh YJ, Kundu JK. Cancer preventive phytochemicals as speed breakers in inflammatory signaling involved in aberrant COX-2 expression. Current Cancer Drug Targets. 2007;5:447–458
  11. Ferguson LR, Philpot M. Cancer prevention by dietary bioactive components that target the immune response. Current Cancer Drug Targets. 2007;5:459–464
  12. Singh RP, Agarwal R. Inducible nitric oxide synthase-vascular endothelial growth factor axis: a potential target to inhibit tumor angiogenesis by dietary agents. Current Cancer Drug Targets. 2007;5:475–483
  13. Davis CD, Milner JA. Molecular targets for nutritional preemption of cancer. Current Cancer Drug Targets. 2007;5:410–415
  14. Sarkar FH, Li Y. Targeting multiple signal pathways by chemopreventive agents for cancer prevention and therapy. Acta Pharmacol Sin. 2007;28:1305–1315
  15. Hanahan D, Weinburg RA. The hallmarks of cancer. Cell. 2000;100:57–70
  16. Meeran SM, Katiyar SK. Cell cycle control as a basis for cancer chemoprevention through dietary agents. Frontiers Biosci. 2008;13:2191–2202
  17. Mailand N, Falck J, Lukas C, et al. Rapid destruction of human Cdc25A in response to DNA damage. Science. 2000;288:1425–1429
  18. Macaluso M, Montanari M, Cinti C, Giordano A. Modulation of cell cycle components by epigenetic and genetic events. Semin Oncol. 2005;32:452–457
  19. Thangapazham RL, Singh AK, Sharma A, Warren J, Gaddipati JP, Maheshwai RK. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo. Cancer Lett. 2007;245:232–241
  20. Li Z, Li J, Mo B, Hu C, et al. Genistein induces G2/M cell cycle arrest via stable activation of ERK ½ pathway in MDA-MB-231 breast cancer cells. Cell Bio Toxicol. 2008;24:401–409
  21. Park C, Kim GY, Kim GD, Choi BT, Park YM, Choi YH. Induction of G2/M arrest and inhibition of cyclooxyagenase-2 activity by curcumin in human bladder cancer T24 cell. Oncol Rep. 2006;15:1225–1231
  22. Shukla S, Gupta S. Apigenin suppresses insulin-like growth factor 1 receprot signaling in human prostate cancer: an in vitro and in vivo study. Mol Carcinog. 2009;48:243–252
  23. Song JD, Lee SK, Kim KM, et al. Molecular mechanism of diallyl disulfide in cell cycle arrest and apoptosis in HCT-116 colon cancer cells. J Biochem Mol Toxicol. 2009;23:71–79
  24. Colin D, Gimazane A, Lizard G, et al. Effects pf resveratrol analogs on cell cycle progression, cell cycle associated proteins and 5fluoro-uracil sensitivity in human derived colon cancer cells. Int J Cancer. 2009;124:2780–2788
  25. Jeong JH, An JY, Kwon YT, Rhee JG, Lee YJ. Effects of low dose quercetin: cancer cell-specific inhibition of cell cycle progression. J Cell Biochem. 2009;106:73–82
  26. Wang L, Liu D, Ahmed T, Chung FL, Conaway C, Chiao JW. Targeting cell cycle machinery as a molecular mechanism of sulforaphane in prostate cancer prevention. Int J Cancer. 2004;24:187–192
  27. Deep G, Oberlies NH, Kroll DJ, Agarwal R. Identifying the differential effects of silymarin constituents on cell growth and cell cycle regulatory molecules in human prostate cancer cells. Int J Cancer. 2008;123:41–50
  28. Li TM, Chen GW, Su CC, et al. Ellagic acid induced p53/p21 expression, G1 arrest and apoptosis in human bladder T24 cells. Anticancer Res. 2005;25:971–979
  29. Dong Y, Zhang H, Hawthorn L, Ganther HE, Ip C. Delineation of the molecular basis for selenium-induced growth arrest in human prostate cancer cells by oligonucleotide array. Cancer Res. 2003;63:52–59
  30. Yokota T, Matsuzaki Y, Koyama M, et al. Sesamin, a lignan of sesame, down-regulates cyclin D1 protein expression in human tumor cells. Cancer Sci. 2007;98:1447–1553
  31. Fresco P, Borges F, Diniz C, Marques MP. New insights on the anticancer properties of dietary polyphenols. Med Res Rev. 2006;26:747–766
  32. Semczuk A, Jakowicki JA. Alterations of pRB1-cyclin D1-cdk4/6-p16(INK4A) pathway in endometrial carcinogenesis. Cancer Lett. 2004;203:1–12
  33. Shankar S, Suthakar G, Srivastava RK. Epigallocatechin-3-gallate inhibits cell cycle and induces apoptosis in pancreatic cancer. Front Biosci. 2007;12:5039–5051
  34. Park H, Han D, Park YH, Park J. Differential biological responses of green tea polyphenol in normal cells vs. cancer cells. Curr Appl Phys. 2005;5:449–452
  35. Nguyen HH, Aronchik I, Brar GA, et al. The dietary phytochemical indole-3-carbinol is a natural elastase enzymatic inhibitor that disrupts cyclin E protein processing. Proc Natl Acad Sci U S A. 2008;105:19750–19755
  36. Benitz DA, Pozo-Guisado E, Alvarez-Barrientos A, Fernandez-Salguero PM, Castellon EA. Mechanisms involved in resveratrol-induced apoptosis and cell cycle arrest in prostate cancer derived cell lines. J Androl. 2007;28:282–293
  37. Suh N, Luyengi L, Fong HH, Kinghorn AD, Pezzuto JM. Discovery of natural product chemopreventive agents using HL-60 cell differentiation as a model. Anticancer Res. 1995;15:233–239
  38. Howell LM, Moiseeva EP, Neal CP, et al. Predicting the physiological relevance of in vitro cancer preventive activities of phytochemicals. Acta Pharmacol Sin. 2007;28:1274–1304
  39. Wang L, Liu D, Ahmed T, Chun FL, Conaway C, Chiao JW. Targeting cell cycle machinery as a molecular mechanism of sulforaphane in prostate cancer prevention. Int J Oncol. 2004;24:187–192
  40. Jackson SJ, Singletary KW. Sulforaphane inhibits human MCF-7 mammary cancer cell mitotic progression and tubulin polymerization. J Nutr. 2004;134:2229–2236
  41. Parnaud G, Li P, Cassar G, et al. Mechanism of sulforaphane-induced cell cycle arrest and apoptosis in human colon cancer cells. Nutr Cancer. 2004;48:198–206
  42. Singh SV, Herman-Antosiewicz A, Singh AV, et al. Sulforaphane-induced G2/M phase cell cycle arrest involves checkpoint kinase 2-mediated phosphorylation of cell division cycle 25C. J Biol Chem. 2004;279:25813–25822
  43. Tang L, Zhang Y. Mitochondria are the primary target in isothiocyanate-induced apoptosis in human bladder cancer cells. Mol Cancer Ther. 2005;4:1250–1259
  44. El Toumy LH, Banerfee PP. Identification of a biphasic role for genistein in the regulation of prostate cancer growth and metastasis. Cancer Res. 2009;69:3695–3703
  45. Hsieh TC, Wu JM. Suppression of cell proliferation and gene expression by combinatorial synergy of EGCG, resveratrol and γ-tocotrienol in estrogen receptor-positive MCF-7 breast cancer cells. Int J Oncol. 2008;33:851–859
  46. Schlachterman A, Valle F, Wall KM, et al. Combined resveratrol, quercetin, and catechin treatment reduces breast tumor growth in a nude mouse model. Transl Oncol. 2008;1:19–27
  47. Shukla S, Gupta S. Apigenin-induced cell cycle arrest is mediated by modulation of MAPK, P13K-Akt, and loss of cyclin D1 associated retinoblastoma dephosphorylation in human prostate cancer cells. Cell Cycle. 2007;6:1102–1114
  48. Shukla S, Gupta S. Molecular targets for apigenin-induced cell cycle arrest and apoptosis in prostate cancer cell xenograft. Mol Cancer Ther. 2006;4:843–852
  49. Hollman PC, Katan MB. Health effects and bioavailability of dietary flavanols. Free Radic Res. 1999;S1:75–80
  50. Srivastava RK, Chen Q, Siddiqui I, Sarva K, Shankar S. Linkage of curcumin-induced cell cycle arrest and apoptosis by cyclin-dependent kinase inhibitor p21/WAF1/CIP1. Cell Cycle. 2007;6:2953–2961
  51. Chuang SE, Cheng AL, Lin JK, Kuo ML. Inhibition by curcumin of dietylnitrosamine-induced hepatic hyperplasi, inflammation, cellular gene products and cell-cycle-related proteins in rats. Food Chem Toxicol. 2000;38:991–995
  52. Khafif A, Schantz SP, Chou TC, Edelstein D, Sacks PG. Quantittation of chemopreventive synergism between (−)-epigallocatechin-3-gallate and curcumin in normal, premalignant and malignant human oral epithelial cells. Carcinogenesis. 1998;19:419–424
  53. Lin N, Chen X, Liao J, et al. Inhibition of 7,12-dimethylbenz{a}antrhracene (DMBA)-induced oral carcinogenesis in hamsters by tea and curcumin. Carcinogenesis. 2002;23:1307–1313
  54. Holt PR, Wolper C, Moss SF, Yang K, Lipkin M. Comparison of low-fat dairy foods on epithelial cell proliferation and differentiation. Nutr Cancer. 2001;41:150–155
  55. Rozen P, Lubin F, Papo N, et al. Calcium supplements interact significantly with long-term diet while suppressing rectal epithelial proliferation of adenoma patients. Cancer. 2001;91:833–840
  56. Weerasooriya V, Rennie MJ, Anant S, et al. Dietary fiber decreases colonic epithelial cell proliferation and protein synthetic rates in human subjects. Am J Physiol Endocrinol Metab. 2006;290:E1104–E1108
  57. Fedirko V, Bostick RM, Flanders WD, et al. Effects of vitamin D and calcium on proliferation and differentiation in normal colon mucosa: a randomized clinical trial. Cancer Epidemiol Biomarkers Prev. 2009;18:2933–2941
  58. Worthley DL, Le Leu RK, Conlon M, et al. A human, double-blind, placebo-controlled, crossover trial of prebiotic, probiotic, and synbiotic supplementation: effects on luminal, inflammatory, epigenetic, and epithelial biomarkers of colorectal cancer. Am J Clin Nutr. 2009;90:578–586
  59. Kristal AR, Blount PL, et al. Low-fat, high fruit and vegetable diets and weight loss do not affect biomarkers of cellular proliferation in Barrett esophagus. Cancer Epidemiol Biomarkers Prev. 2005;14:2377–2383
  60. Sun SY, Hail N, Lotan R. Apoptosis as a novel target for cancer chemoprevention. J Natl Cancer Inst. 2004;96:662–672
  61. Rodriguez M, Schaper J. Apoptosis: measurement and technical issues. J Mol Cell Cardiol. 2005;38:15–20
  62. Saleem M, Kweon MH, Yun JM, et al. A novel dietary triterpene leueol induces fas-mediated apoptotic death of androgen-sensitive prostate cancer cells and inhibits tumor growth in a xenograft model. Cancer Res. 2005;65:11203–11213
  63. Pledgie-Tracy A, Sobolewski MD, Davidson NE. Sulforaphane induces cell type-specific apoptosis in human breast cancer cell lines. Mol Cancer Ther. 2007;6:1013–1021
  64. Deeb D, Jiang H, Gao X, et al. Curcumin [1,7-Bis(4-hydroxy-3-methoxyphenyl)-1-6-heptadine-3,5-dione] sensitizes human prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L-induced apoptosis by suppress8ing nuclear factor-6B via inhibition of the prosurivial Akt signaling pathway. J Pharmacol Experimental Ther. 2007;321:616–625
  65. Zhang S, Shen HM, Ong CN. Down-regulation of c-FLIP contributes to the sensitization effect of 3,3′-diindolylmethane on TRAIL-induced apoptosis in cancer cells. Mol Cancer Ther. 2005;4:1972–1981
  66. Das A, Banik NL, Ray SK. Mechanism of apoptosis with the involvement of calpain and caspase cascades in human malignant neuroblastoma SH-SY5Y cells exposed to flavonoids. Int J Cancer. 2006;119:2575–2585
  67. Zou H, Zhan S, Cao K. Apoptotic activity of genistein on human lung adenocarcinoma SPC-A-1 cells and preliminary exploration of its mechanisms using microarray. Biomed Pharmacother. 2008;62:583–589
  68. Cao J, Liu Y, Zhou HM, et al. Curcumin induces apoptosis through mitochondrial hyperpolization and mtDNA damage in human hepatoma G2 cells. Free Radic Med Biol. 2007;43:968–975
  69. Choi WY, Choi BT, Lee WH, Choi YH. Sulforaphane generates reactive oxygen species leading to mitochondrial perturbation for apoptosis in human leukemia U937 cells. Biomed Pharmacother. 2008;62:637–644
  70. Palozza P, Serini S, Torsello A, et al. Mechanisms of activation of caspase cascade during beta-carotene-induced apoptosis in human tumor cells. Nutr Cancer. 2003;47:76–87
  71. Zhou HB, Chen JM, Cai JT, Du Q, Wu CN. Anticancer activity of genistein on implanted tumor of human SG7901 cells in nude mice. World J Gastronenterol. 2008;14:627–631
  72. Thangapazham RL, Passi N, Maheshwair RK. Green tea polyphenol and epigallocatechin gallate induce apoptosis and inhibit invasion in human breast cancer cells. Cancer Biol Ther. 2007;6:1938–1943
  73. Shukla S, Gupta S. Apigenin-induced prostate cancer cell death is initiated by reactive oxygen species and p53 activation. Free Radic Biol Med. 2008;44:1833–1845
  74. Yang SF, Yang WE, Chang HR, Chu SC, Hsieh YS. Luteolin induces apoptosis in oral squamous cancer cells. J Dent Res. 2008;87:401–406
  75. Das A, Banik NL, Ray SK. Garlic compounds generate reactive oxygen species leading to activation of stress kinases and cysteine proteases for apoptosis in human glioblastoma T98G and U87MG cells. Cancer. 2007;110:1083–1094
  76. Xiang N, Zhao R, Zhong W. Sodium selenite induces apoptosis by generation of superoxide via the mitochondrial-dependent pathway in human prostate cancer cells. Cancer Chemother Pharmacol. 2009;63:351–362
  77. Alkhalaf M, El- Mowafy A, Renno W, Rachid O, Ali A, Al-Attyiah R. Resveratrol-induced apoptosis in human breast cancer cells is mediated primarily through the caspase-3-dependent pathway. Arch Med Res. 2008;39:162–168
  78. Zhang Q, Zhao XH, Wang ZJ. Cytotoxicity of flavones and flavonols to a human esophageal squamous cell carcinoma cell line (KYSE-510) by induction of G(2)/M arrest and apoptosis. Toxicol In Vitro. 2009;23:797–807
  79. Krammer PH. CD95's deadly mission in the immune system. Nature. 2000;407:789–795
  80. Hastak K, Agarwal MK, Mukhtar , agarwal ML. Ablation of either p21 or Bax prevent p53-dependent apoptosis induced by green tea polypheon epigallocatechin-3-gallate. FASEB J. 2005;19:789–791
  81. Huang C, Ma WK, Goranson A, Dong Z. Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway. Carcinogenesis. 1999;20:237–242
  82. Chen C, Kong AN. Dietary cancer-chemopreventive compounds: from signaling and gene expression to pharmacological effects. Trends Pharmacol Sci. 2005;26:318–326
  83. Nair HK, Rao KV, Aalinkeel R, Mahajan S, Chawda R, Schwartz SA. Inhibition of prostate cancer cell colony formation by the flavonoid quercetin correlates with modulation of specific regulatory genes. Clin Diagn Lab Immunol. 2004;11:63–69
  84. Yang CS, Chen L, Lee MJ, Balentine D, Kuo MC, Schantz SP. Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers. Cancer Epidemiol Biomarkers Prev. 1998;7:351–354
  85. Chow HH, Cai Y, Alberts DS, et al. Phase 1 pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E. Cancer Epidemiol Biomarkers Prev. 2001;10:53–58
  86. Nemeth K, Piskula MK. Food content, processing, absorption and metabolism of onion flavonoids. Crit Rev Food Sci Nutr. 2007;47:397–409
  87. Kim YH, Lee DH, Jeong JH, Guo ZS, Lee YJ. Quercetin augments TRAIL-induced apoptotic death: involvement of the ERK signal transduction pathway. Biochem Pharmacol. 2008;75:1946–1958
  88. Mouria M, Gukovskaya AS, Jung Y, et al. Food-derived polyphenols inhibit pancreatic cancer growth through mitochondrial cytochrome C release and apoptosis. Int J Cancer. 2002;98:761–769
  89. Mertens-Talcott SU, Percival SS. Ellagic acid and quercetin interact synergistically with resveratrol in the induction of apoptosis and cause transient cell cycle arrest in human leukemia cells. Cancer Lett. 2005;218:141–151
  90. Zu K, Ip C. Synergy between selenium and vitamin E in apoptosis induction is associated with activation of distinctive initiator caspases in human prostate cancer cells. Cancer Res. 2003;63:6988–6995
  91. Davis CD. Nutritional interactions: credentialing of molecular targets for cancer prevention. Exp Biol Med. 2007;232:176–183
  92. Kim HS, Bowen P, Chen L, et al. Effects of tomato sauce consumption on apoptotic cell death in prostate benign hyperplasia and carcinoma. Nutr Cancer. 2003;47:40–47
  93. Jarred RA, Keikha M, Dowling C, et al. Induction of apoptosis in low to moderate-grade human prostate carcinoma by red clover-derived dietary isoflavones. Cancer Epidemiol Biomarkers Prev. 2002;11:1689–1696
  94. Miller EA, Keku TO, Satia JA, Martin CF, Galanko JA, Sandler RS. Calcium, vitamin D and apoptosis in the rectal epithelium. Cancer Epidemiol Biomarkers Prev. 2005;14:525–528
  95. Presta M, Dell'Era P, Mitola S, Moroni E, Ronca R, Rusnati M. Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. Cytokine Growth Factor Rev. 2005;16:159–178
  96. Albini A, Tosetti F, Benelli R, Noonan DM. Tumor inflammatory angiogenesis and chemoprevention. Cancer Res. 2005;65:10637–10641
  97. Pfeffer U, Ferrari N, Morini M, Benelli R, Noonan DM, Albini A. Antioangiogenic activity of chemopreventive drugs. Int J Biol Markers. 2003;18:70–74
  98. Cockett MI, Murphy G, Birch ML, et al. Matrix metalloproteinases and metastatic cancer. Biochem Soc Symp. 1998;63:295–313
  99. Ii M, Yamamoto H, Adachi Y, Maruyama Y, Shinomura Y. Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth and angiogenesis. Exp Biol Med. 2006;31:20–27
  100. Bisacchi D, Benelli R, Vanzetto C, Ferrari N, Tosetti F, Albini A. Antiangiogenesis and angioprevention: mechanisms, problems and perspectives. Cancer Detect Prev. 2008;27:229–238
  101. Westermarck J, Kahari VM. Regulation of matrix metallopreoteinase expression in tumor invasion. FASEB J. 1999;13:781–792
  102. Singh RP, Agarwal R. Inducible nitric oxide synthase-vascular endothelial growth factor axis: a potential target to inhibit tumor angiogenesis by dietary agents. Curr Cancer Drug Targets. 2007;7:475–483
  103. Bhat TA, Singh RP. Tumor angiogenesis—a potential target in cancer chemoprevention. Food Chem Toxicol. 2008;46:1334–1345
  104. Dulak J. Nutraceuticals as anti-angiogenic agents: hopes and reality. J Physiol Pharmacol. 2005;56:51–69
  105. Aggarwal BB, Shishodia S, Sandur SK, Pandey MK, Sethi G. Inflammation and cancer: how hot is the link?. Biochem Pharmacol. 2006;72:1605–1621
  106. Maeda S, Omata M. Inflammation and cancer: role of nuclear factor-kappaB activation. Cancer Sci. 2008;99:836–842
  107. Yu H, Jove R. The STATs of cancer: new molecular targets come of age. Nat Rev Cancer. 2004;4:97–105
  108. Bhutani M, Pathak AK, Nair AS, et al. Capsaicin is a novel blocker of constitutive and interleukin-6-inducible STAT3 activation. Clin Cancer Res. 2007;13:3024–3032
  109. Lee IO, Lee KH, Pyo JH, Kim JH, Choi YJ, Lee YC. Anti-inflammatory effect of capsaicin in Helicobacter pylori-infected gastric epithelial cells. Helicobacter. 2007;12:510–517
  110. Bhardwaj A, Sethi G, Vadhan-Raj S, et al. Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-kappaB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells. Blood. 2007;109:2293–2302
  111. Aggarwal BB, Vijayalekshmi RV, Sung B. Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe. Clin Cancer Res. 2009;15:425–430
  112. Dhillon N, Aggarwal BB, Newman RA, et al. Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin Cancer Res. 2008;14:4491–4499
  113. Chinnakannu K, Chen D, Li Y, Wang Z, Dou QP, Reddy GP, et al. Cell cycle-dependent effects of 3,3′-diindolylmethane on proliferation and apoptosis of prostate cancer cells. J Cell Physiol. 2009;219:94–99
  114. Yun JM, Afaq F, Khan N, Mukhtar H. Delphinidin, an anthocyanidin in pigmented fruits and vegetables, induces apoptosis and cell cycle arrest in human colon cancer HCT116 cells. Mol Carcinog. 2009;48:260–270
  115. Hafeez BB, Siddiqui IA, Asim M, et al. A dietary anthocyanidin delphinidin induces apoptosis of human prostate cancer PC3 cells in vitro and in vivo: involvement of nuclear factor-kappaB signaling. Cancer Res. 2008;68:8564–8572
  116. Mentor-Marcel RA, Bobe G, Barrett KG, et al. Inflammation-associated serum and colon markers as indicators of dietary attenuation of colon carcinogenesis in ob/ob mice. Cancer Prev Res. 2009;2:60–69
  117. Jain SK, Rains J, Croad J, Larson B, Jones K. Curcumin supplementation lowers TNF-alpha, IL-6, IL-8, and MCP-1 secretion in high glucose-treated cultured monocytes and blood levels of TNF-alpha, IL-6, MCP-1, glucose, and glycosylated hemoglobin in diabetic rats. Antioxid Redox Signal. 2009;11:241–249
  118. Nonn L, Duong D, Peehl DM. Chemopreventive anti-inflammatory activities of curcumin and other phytochemicals mediated by MAP kinase phosphatase-5 in prostate cells. Carcinogenesis. 2007;28:1188–1196
  119. Bergman Jungeström M, Thompson LU, Dabrosin C. Flaxseed and its lignans inhibit estradiol-induced growth, angiogenesis, and secretion of vascular endothelial growth factor in human breast cancer xenografts in vivo. Clin Cancer Res. 2007;13:1061–1067
  120. Chen T, Rose ME, Hwang H, Nines RG, Stoner GD. Black raspberries inhibit N-nitrosomethylbenzylamine (NMBA)-induced angiogenesis in rat esophagus parallel to the suppression of COX-2 and iNOS. Carcinogenesis. 2006;27:2301–2307
  121. Rodrigo KA, Rawal Y, Renner RJ, et al. Suppression of the tumorigenic phenotype in human oral squamous cell carcinoma cells by an ethanol extract derived from freeze-dried black raspberries. Nutr Cancer. 2006;54:58–68
  122. Roy S, Khanna S, Alessio HM, et al. Anti-angiogenic property of edible berries. Free Radic Res. 2002;36:1023–1031
  123. Min JK, Han KY, Kim EC, et al. Capsaicin inhibits in vitro and in vivo angiogenesis. Cancer Res. 2004;64:644–651
  124. Pyun BJ, Choi S, Lee Y, et al. Capsiate, a nonpungent capsaicin-like compound, inhibits angiogenesis and vascular permeability via a direct inhibition of Src kinase activity. Cancer Res. 2008;68:227–235
  125. Wallez Y, Cand F, Cruzalegui F, et al. Src kinase phosphorylates vascular endothelial-cadherin in response to vascular endothelial growth factor: identification of tyrosine 685 as the unique target site. Oncogene. 2007;26:1067–1077
  126. Chang X, Tou JC, Hong C, et al. 3,3′-Diindolylmethane inhibits angiogenesis and the growth of transplantable human breast carcinoma in athymic mice. Carcinogenesis. 2005;26:771–778
  127. Calder PC. Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases. Mol Nutr Food Res. 2008;52:885–897
  128. Asaumi H, Watanabe S, Taguchi M, et al. Green tea polyphenol (–)-epigallocatechin-3-gallate inhibits ethanol-induced activation of pancreatic stellate cells. Eur J Clin Invest. 2006;36:113–122
  129. Cao Z, Fang J, Xia C, Shi X, Jiang BH. Trans-3,4,5′-trihydroxystibene inhibits hypoxia-inducible factor 1alpha and vascular endothelial growth factor expression in human ovarian cancer cells. Clin Cancer Res. 2004;10:5253–5263
  130. Zhang Q, Tang X, Lu QY, Zhang ZF, Brown J, Le AD. Resveratrol inhibits hypoxia-induced accumulation of hypoxia-inducible factor-1alpha and VEGF expression in human tongue squamous cell carcinoma and hepatoma cells. Mol Cancer Ther. 2005;4:1465–1474
  131. Zhang Q, Tang X, Lu Q, Zhang Z, Rao J, Le AD. Green tea extract and (−)-epigallocatechin-3-gallate inhibit hypoxia- and serum-induced HIF-1alpha protein accumulation and VEGF expression in human cervical carcinoma and hepatoma cells. Mol Cancer Ther. 2006;5:1227–1238
  132. Mukherjee P, Sotnikov AV, Mangian HJ, et al. Energy intake and prostate tumor growth, angiogeneis, and vascular endothelial growth factor expression. J Natl Cancer Inst. 1999;91:512–523
  133. Mukherjee P, Al-Abbadi MM, Kasperzyk JL, Ranes MK, Seyfried TN. Dietary restriction reduces angiogenesis and growth in an orthotopic mouse brain tumour model. Br J Cancer. 2002;86:1615–1621
  134. Powolny AA, Wang S, Carlton PS, Hoot DR, Clinton SK. Interrelationships between dietary restriction, the IGF-1 axis, and the expression of vascular endothelial growth factor by prostate adenocarcinoma in rats. Mol Carcinog. 2008;47:458–465
  135. Lairon D, Defoort C, Martin JC, Amiot-Carlin MJ, Gastaldi M, Planells R. Nutrigenetics: links between genetic background and response to Mediterranean-type diets. Public Health Nutr. 2009;12:1601–1606
  136. Oyagbemi AA, Azeez OL, Saba AB. Interactions between reactive oxygen species and cancer: the roles of natural dietary antioxidants and their molecular mechanisms of action. Asian Pac J Cancer Prev. 2009;10:535–544
  137. Seifried HE, Anderson DE, Fisher EI, Milner JA. A review of the interactions among dietary antioxidants and reactive oxygen species. J Nutr Biochem. 2007;18:567–579

PII: S0093-7754(10)00066-7

doi: 10.1053/j.seminoncol.2010.05.001

Seminars in Oncology
Volume 37, Issue 3 , Pages 243-257 , June 2010